5 Feb 2026Open access
Early Experience of High‑Dose‑Rate Interstitial Brachytherapy for Prostate Cancer in NigeriaPublisher siteOpen MIND, Prostate Cancer Diagnosis and Treatment
Active, last published 2026
In prostate cancer diagnosis and treatment
Babatunde Olutoye
Ogunnorin
Scholar“Research focused on Prostate Cancer Diagnosis and Treatment and adjacent fields.”
Claim Your Profile1
H-index
19
Citations
Babatunde has not officially claimed their profile. If you are Babatunde, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
abatunde Olutoye Ogunnorin is a researcher working on Prostate Cancer Diagnosis and Treatment. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Babatunde's work has been cited 19 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Prostate Cancer Diagnosis and Treatment×2Advances in Oncology and Radiotherapy×2
04 · Where I am
Affiliations
Affiliation on published researchUniversity College Hospital, Ibadan, NigeriaDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
2 works1 Jan 2023Open access1cites
Early Experience of High-Dose-Rate Interstitial Brachytherapy for Prostate Cancer in NigeriaPublisher siteJournal of Radiation Medicine in the Tropics, Prostate Cancer Diagnosis and Treatment
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Babatunde?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you